2024-02-22 08:10:39
According to the study, despite the increased rates of side effects, the objectively real number of such complications and deaths from them is small. Especially when compared with the number of deaths from covid
Scientists conducted a global study on the side effects of vaccination once morest Covid, in which they analyzed 99 million vaccinated people, AiF reports, citing the journal Vaccine.
For the study, experts took vaccines such as Pfizer, Moderna and AstraZeneca. As a result, experts concluded that side effects following vaccinations occurred more often than previously thought.
Thus, following the AstraZeneca vaccine, Guillain-Barré syndrome, which affects the nervous system, was 2.49 times more common. The mortality rate for this syndrome is 3–5%, approximately the same figures for coronavirus. Most patients recover.
Almost 4 times more often, those vaccinated with Moderna developed acute disseminated encephalomyelitis (a special inflammation of the brain). If scientists assumed that in absolute numbers it would appear in two people, then in fact it was detected in seven.
Heart pathologies have also been linked to Pfizer and Moderna. After the first dose of Moderna, myocarditis was diagnosed 3.48 times more often, and following the second – 6.1 times. Pfizer has slightly better indicators – 2.78 and 2.86, respectively. At the same time, the mortality rate from post-vaccination myocarditis is two to three times lower than from coronavirus. The statistics are approximately the same for pericarditis – inflammation of the heart sac.
At the same time, scientists emphasize that even updated data on complications from vaccinations cannot be compared with the mortality rate from coronavirus. Thus, the chances of dying from infection are 1333–2000 times greater than getting Guillain-Barré syndrome following vaccination.
Since March 2020, more than 13.5 billion doses of COVID-19 vaccines have been administered worldwide, saving the lives of millions of people, with only a few thousand side effects diagnosed. This is, of course, a tragedy, but on a different scale.
Previously, Altai scientists developed a special class of coronavirus blockers. They took the Mpro protease (3CLpro), which is key in the life cycle of COVID-19, as a target to fight the infection.
1708653433
#study #complications #coronavirus #vaccination #showed